The role of vitamin D through SphK1/S1P in the regulation of MS progression

• Published in: The Journal of steroid biochemistry and molecular biology 2024-02, Vol.236, p.106425-106425, Article 106425
• Main Authors: Wang, Zhen, Yi, Shu-Ying, Zhang, Yuan-Ying, Wang, Yu-di, Chen, Han-Lin, Guo, Yi-Jie, Wei, Xin-Ming, Yang, Du-Xiao
• Format: Article
• Language: English
• Subjects: Animals; bcl-2-Associated X Protein; Encephalomyelitis, Autoimmune, Experimental - drug therapy; Interleukin-6; Lysophospholipids - metabolism; Multiple Sclerosis; Phosphotransferases (Alcohol Group Acceptor); Rats; Sphingosine - metabolism; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha - genetics; Vitamin D - pharmacology; Vitamins
• ISSN: 0960-0760; 1879-1220
• DOI: 10.1016/j.jsbmb.2023.106425

Sphingosine-1-phosphate (S1P) is biologically active lipid, leading to neuroinflammation and macrophage invasion in central nervous system, plays an important role in the development of multiple sclerosis (MS) model in experimental allergic encephalomyelitis (EAE) rats. Vitamin D is observed to be a key factor in regulating cell S1P levels. We detected vitamin D can alleviate the symptoms of EAE rats, but the exact mechanism is unclear. In PC12 cells, vitamin D can reverse S1P-induced cell death, but the signaling pathway unclear. This study was aimed to investigate S1P regulation mechanism or signaling pathway mediated by vitamin D in EAE and PC12 model. In our experiments, S1P and Sphingosine kinase type 1 (SphK1) mRNA and protein expression in EAE rats group, control group, vitamin D feeding group were detected by HPLC, ELISA, RT-PCR and western blot. PC12 cell death was detected by Propidium (PI) staining. VDR plasmid overexpression and RNA interference, immunofluorescence, real-time cell analysis, protein immunoblotting was used to detect SphK1 transcriptional regulation, cell-substrate attachment quality, the signaling pathway of cell apoptosis and inflammation related gene expression (Bax/Bcl-2, Casepase-3, Il-6, TGF-β, TNF-α). Our study showed vitamin D can reverse the elevation of S1P level in EAE rats, reduce the severity and shorten the course of EAE. 1,25-(OH) D coupled with vitamin D receptor (VDR) inhibited SphK1 transcription. 1,25-(OH) D significantly reduced PC12 cell death rate induced by S1P, in addition improved the cell substrate attachment quality. 1,25-(OH) D can block S1P-induced p-ERK activation and PI3K /Akt signaling pathway reduced Il-6, TGF-β, TNF-α cytokine release and Bax/Bcl-2, Casepase-3 apoptosis protein expression. On the other hand, immunofluorescence staining showed 1,25-(OH) D can increase the expression of neuronal perinuclear protein MAP2 in PC12 cells probably protect nerve cells further. In summary, the ameliorative effect of vitamin D was derived from its ability to reduce S1P levels, provides an idea for vitamin D as a combination therapy for disease.